Articles

"Det räcker att en lyckas"-biotechportfölj förvärvat till ett värde lägre än kassamedlen

Zenostocks databas innehåller 3674 st aktier med hemland USA. De tio billigaste av dessa (samtliga företag oavsett marknadsvärde) har alla ett drag gemensamt - en nettokassa som är större än företagets hela marknadsvärde. Hela nio st. av dessa är biotech-företag, läkemedelsutvecklare.

This content is for subscribers only. Register for free trial period. Registering for a trial version is completely free.

RegisterLogin

The contents of this article does not constitute investment research, financial analysis or investment advice. The contents of this article may not be considered as a recommendation to either buy or sell stock or other investment instruments. No guarantees regarding the correctness of the contents of this article can be given. In case the reader of this article wants to form an opinion regarding stock or other investment instruments for a possible investment decision, the reader solely is responsible for this. In this case we recommend that the reader, either by his own or together with his/her possible investment adviser, gather additional information regarding the matter.

Zenito Oy publishes articles regarding subjects Zenito Oy considers interesting from some perspective. This does not implicate that the subject, viewed objectively, is interesting or relevant.